Quilizumab (anti-IgE) - Primary antibody, specific to IGHE, Human IgG1, Antibody of immunoglobulin heavy constant epsilon

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
Features and benefits
  • Host species: Human
  • Species reactivity(Reacts with): Human
  • Isotype: Human IgG1
  • Conjugation: Unconjugated
Item Number
Ab175636
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab175636-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$89.90
Ab175636-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$419.90
Ab175636-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,089.90
Ab175636-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,749.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product NameQuilizumab (anti-IgE) - Primary antibody, specific to IGHE, Human IgG1
SynonymsIgh2 antibodyIGHE antibody | IGHEP1 antibody | Immunoglobulin heavy constant epsilon antibody | IgE | immunoglobulin heavy constant epsilon | Anti-Human NGcGM3 Recombinant Antibody
Specifications & PurityExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
Host speciesHuman
SpecificityIGHE
ConjugationUnconjugated
GradeAzide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action TypeINHIBITOR
Mechanism of actionAntibody of immunoglobulin heavy constant epsilon
Product Description

Quilizumab (anti-IgE) is a humanized IgG1κ monoclonal antibody. Quilizumab (anti-IgE) targets the M1-prime segment of membrane-expressed IgE, leading to depletion of IgE-switched and memory B cells. Quilizumab (anti-IgE) has the potantial for the asthma research.
Purity
>95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

Product Properties

IsotypeHuman IgG1
Light Chain Typekappa
SDS-PAGE146.5 kDa
Purification MethodProtein A purified
FormLiquid
ConcentrationLot by Lot
Storage TempStore at -80°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS1228538-47-3

Associated Targets(Human)

IGHE Tclin Immunoglobulin heavy constant epsilon (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Gauvreau GM, Harris JM, Boulet LP, Scheerens H, Fitzgerald JM, Putnam WS, Cockcroft DW, Davis BE, Leigh R, Zheng Y et al..  (2014)  Targeting membrane-expressed IgE B cell receptor with an antibody to the M1 prime epitope reduces IgE production..  Sci Transl Med,  (243): (243ra85).  [PMID:24990880] [10.1021/op500134e]
2. Pennington LF, Gasser P, Brigger D, Guntern P, Eggel A, Jardetzky TS.  (2021)  Structure-guided design of ultrapotent disruptive IgE inhibitors to rapidly terminate acute allergic reactions..  J Allergy Clin Immunol,  71  (13): (1755-70).  [PMID:33991582] [10.1016/j.jaci.2021.03.050]
3. Kolkhir P, Altrichter S, Munoz M, Hawro T, Maurer M.  (2020)  New treatments for chronic urticaria..  Ann Allergy Asthma Immunol,  124  (1): (2-12).  [PMID:31446134] [10.1021/op500134e]

Solution Calculators